- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Daratumumab
Total 315 results
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Janssen Research & Development, LLCRecruitingAmyloidosisCanada, Italy, United States, Greece, China, Netherlands, Spain, France, Germany, United Kingdom
-
Janssen Research & Development, LLCActive, not recruitingAmyloidosisUnited States, Netherlands, Belgium, Korea, Republic of, France, Sweden, Israel, Turkey, United Kingdom, Brazil, Canada, Mexico, Australia, Germany, Japan, Spain, Denmark, Italy, China, Greece, Poland, Hungary
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
European Myeloma NetworkJanssen, LPActive, not recruitingMultiple Myeloma | Extramedullary PlasmacytomaTurkey, Italy, Greece
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaUnited States
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
University Hospital, ToulouseRecruiting
-
PfizerRecruitingMultiple MyelomaChina, Korea, Republic of, Taiwan, United States, Australia, Japan, Spain, Czechia, United Kingdom, Canada, Germany, New Zealand, Italy, France, Sweden, Poland, Netherlands, Austria, Mexico, Finland, Argentina, Belgium, Brazil, Greece, ... and more
-
Larysa SanchezJanssen, LPRecruitingNewly Diagnosed Multiple MyelomaUnited States
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCancer Prevention Research Institute of TexasEnrolling by invitationDelirium | Epileptics | NeurolepticsUnited States
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, France, Spain, Czechia
-
Cancer Trials IrelandBristol-Myers Squibb; Janssen PharmaceuticalsActive, not recruiting
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
University of Turin, ItalyRecruiting
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityCompleted
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, Japan, United Kingdom, France, Brazil
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
Hoffmann-La RocheCompleted
-
Stichting European Myeloma NetworkJanssen Research & Development, LLCRecruitingMultiple MyelomaNetherlands, Spain, United States, Belgium, France, Italy, Germany, Japan, Canada, Australia, Sweden, Israel, United Kingdom, Czechia, Greece, Switzerland, Norway
-
Emory UniversityNational Cancer Institute (NCI); Takeda; National Institutes of Health (NIH); Janssen...Active, not recruiting
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
VA Office of Research and DevelopmentRecruitingSleep Disordered Breathing | Able BodiedUnited States
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
California Pacific Medical Center Research InstitutePatient-Centered Outcomes Research Institute; University of Pittsburgh; University... and other collaboratorsActive, not recruiting
-
CelgeneNot yet recruitingMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Canadian Myeloma Research GroupCompleted
-
AbbVie (prior sponsor, Abbott)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Secondary AmyloidosisUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Mayo ClinicRecruiting
-
Bristol-Myers SquibbNovartis; Clovis Oncology, Inc.; Janssen Pharmaceuticals; ExelixisRecruitingCancerUnited States, Israel, Spain, Italy, Germany, Australia, Belgium, China, Korea, Republic of, Greece, Japan, Argentina, Austria, Brazil, Canada, Chile, Denmark, Finland, France, Hungary, Ireland, Mexico, Netherlands, Poland, Romania, Russian... and more
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Janssen Research & Development, LLCCompletedPrecursor Cell Lymphoblastic Leukemia-LymphomaUnited States, United Kingdom, France, Sweden, Germany, Spain, Italy, Belgium, Israel, Netherlands
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
M.D. Anderson Cancer CenterTakeda; Janssen PharmaceuticalsActive, not recruitingRecurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary AmyloidosisUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)WithdrawnPlasma Cell MyelomaUnited States
-
University of California, San FranciscoJanssen Pharmaceuticals; Multiple Myeloma Research FoundationTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States